THOR MEDICAL AS

thor-medical-as-logo

Thor Medical AS is a producer and supplier of radionuclides, primarily alpha emitters, for cancer therapy. The production process requires no radiation and provides reliable, low cost supply of sought after ฮฑ-particles.

#SimilarOrganizations #More

THOR MEDICAL AS

Industry:
Medical Medical Device Therapeutics

Status:
Active


Similar Organizations

beams-logo

Beams

Beams is a producer of medical devices for cancerology based on the use of particles ฮฒ.

breeze-mobility-logo

Breeze Mobility

Breeze Mobility is a growing (online and offline) mobility products retailer and wholesaler based in Sydney, Australia.

brosmed-logo

Brosmed

Brosmed is a provider of interventional vascular therapy services.

cardiostory-inc-logo

CardioStory Inc

CardioStory build a Non-Invasive Filling Pressure (NIFP) measurement and monitoring platform for heart failure patients.

not_available_image

Healthcare Plus Supplies

Healthcare Plus Supplies is a medical equipment supplier that provides products and services to local hospices and their patients.

lianzhong-technology-logo

Lianzhong Technology

Lianzhong Technology focuses on the production and sales of chemiluminescence immunoassay systems.

medicons-logo

Medicons

Medicons is a wholesaler of medicines, medical equipment and therapeutic product.

monalisa-touch-logo

MonaLisa Touch

MonaLisa Touch is a clinical laser therapy used in gynecological treatments.

rongsheng-medical-logo

Rongsheng Medical

Rongsheng Medical focuses on the field of precision internal radiation interventional therapy for cancer.

More informations about "Thor Medical AS"

Thor Medical ASA: Disclosure of large shareholdings and โ€ฆ

20.12.2024 14:23:42 CET | Thor Medical ASA | Major shareholding notifications. Oslo, Norway, 20 December 2024: Reference is made to the stock exchange announcement by Thor Medical โ€ฆSee details»

Thor Medical ASA โ€“ Share capital increase in relation to Tranche 1 โ€ฆ

Oslo, Norway, 20 December 2024: Reference is made to stock exchange announcements by Thor Medical ASA (the "Company") on 12 December 2024 regarding the completion of a private โ€ฆSee details»

Thor Medical ASA: Disclosure of large shareholdings and โ€ฆ

3 days ago Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no โ€ฆSee details»

Thor Medical ASA - Share capital increase in relation to Tranche 1 โ€ฆ

3 days ago Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no โ€ฆSee details»

Thor Medical ASA: Disclosure of large shareholding - Euronext Live

3 days ago Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no โ€ฆSee details»

Thor Medical ASA reports first half 2024 results - NTB

Oslo, 30 August 2024: Thor Medical ASA, a leading emerging supplier of alpha-emitters for next-generation precision cancer treatment, today announced results for the first half of 2024. The pilot facilities at Herøya Industrial Park are โ€ฆSee details»

Thor Medical capital markets update: Enabling next-generation โ€ฆ

Nov 24, 2024 "Thor Medical aims to become a world-leading supplier of alpha-emitters for cancer therapies and we have made significant progress towards realizing our ambitions this โ€ฆSee details»

Thor Medical ASA: Notification of trade for close associate of โ€ฆ

Oslo, Norway, 20 December 2024: Scatec Innovation AS, a close associate of board member of Thor Medical ASA John Andersen, has today acquired 1,584,324 shares in Thor Medical ASA โ€ฆSee details»

Thor Medical ASA | LinkedIn

Thor Medical ASA | 5,296 følgere på LinkedIn. Enabling next-generation precision cancer treatments | Thor Medical is an emerging supplier of isotopes for targeted alpha therapies in โ€ฆSee details»

Thor Medical and AdvanCell sign strategic supply agreement for โ€ฆ

4 days ago AlphaOne is Thor Medical's first commercial-scale plant for high-quality radioisotopes. The company recently raised NOK 173 million in gross proceeds in a private โ€ฆSee details»

Thor Medical and ARTBIO sign strategic long-term supply โ€ฆ

Oct 29, 2024 The master supply agreement outlines terms for a 5-year supply of Thorium-228 to ARTBIO, representing revenues for Thor Medical of up to approximately NOK 200 million โ€ฆSee details»

Thor Medical Secures Major Supply Deal with AdvanCell

4 days ago Thor Medical ASA has signed a strategic five-year supply agreement with AdvanCell, marking another milestone for Thorโ€™s AlphaOne plant. The agreement is valued at โ€ฆSee details»

Thor Medical ASA Eyes Leadership in Cancer Treatment

Nov 25, 2024 Thor Medical ASA outlines its strategic vision to become a global leader in alpha-emitters for cancer treatment, highlighting significant milestones such as successful pilot โ€ฆSee details»

News | Thor Medical

Thor Medical ASA โ€“ Share capital increase in relation to Tranche 1 of the Private Placement and the PrimaryBid Offering is registered. December 19, 2024. Thor Medical and AdvanCell sign โ€ฆSee details»

Thor Medical ASA reports first half 2024 results - Pilot facility ...

Aug 30, 2024 Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no โ€ฆSee details»

Thor Medical and ARTBIO sign strategic long-term supply โ€ฆ

Oct 29, 2024 says Jasper Kurth, CEO of Thor Medical. The Thorium-228 will be produced and supplied from Thor Medical's first commercial-scale facility planned at Herøya Industrial Park โ€ฆSee details»

Thor Medical and AdvanCell sign strategic supply agreement for โ€ฆ

Thor Medical Brede Ellingsæter, CFO, +47 472 38 440 [email protected]. ABOUT ADVANCELL. AdvanCell is a vertically integrated, clinical stage radiopharmaceutical โ€ฆSee details»

Thor Medical ASA: Notification of trade for close associate of โ€ฆ

3 days ago Thor Medical ASA from its controlled subsidiary, Scatec Invest II AS, also a close associate of John Andersen, with a price of NOK 2.72 per share, reflecting the last 3 days' โ€ฆSee details»

Thor Medical | Alpha emitters for cancer therapy

The production process is based on a novel technology developed by Thor Medical that combines high efficiency and cost competitive structure with best in class environmental friendliness. โ€ฆSee details»

linkstock.net © 2022. All rights reserved